Background: A scoping review was conducted to examine the breadth of evidence related to
telehealth innovations being utilized in the treatment of opioid use disorder (OUD) with …

Importance Little is known about the potential implications of the rapid transition to telehealth
during the COVID-19 pandemic for treatment of opioid use disorder (OUD). Objective To …

Telemedicine could improve access to medications for opioid use disorder (MOUD).
Telemedicine-delivered MOUD (TMOUD) has expanded substantially in response to the …

Background The majority of individuals with opioid use disorder (OUD) face access barriers
to evidence-based treatment, and the COVID-19 pandemic has exacerbated the United …

Objective To understand patient experience of federal regulatory changes governing
methadone and buprenorphine (MOUD) access in Arizona during the COVID-19 pandemic …

Introduction The COVID-19 pandemic has instigated the development of telemedicine-
mediated provision of medications for opioid use disorder such as buprenorphine and …

Purpose and Approach Women in recovery describe stigma, negative treatment, and limited
support as barriers to achieving their health and parenting goals. Mobile health technologies …

Introduction Regulatory changes made during the COVID-19 public health emergency
(PHE) that relaxed criteria for take-home dosing (THD) of methadone offer an opportunity to …

The COVID-19 pandemic has generated a new reality worldwide and reconfigured
identities, behaviors and interests. It has called for heroic representations and highlighted …

Introduction Since the onset of the COVID-19 pandemic and loosening of some opioid use
disorder (OUD) treatment regulations in the US and Canada, there has been a rapid rise in …